University research records
University of Tripoli
6 imported, source-linked research records. Open-access records.
Open-access records
Back to university profile →6 matching research records
Topic: Canagliflozin and SGLT2. Only records linked to University of Tripoli are included. Historical ingestion is still running; these are imported records, not a count of all research worldwide.
Showing 1–6 of 6 matching records. Counts update as records arrive.
Efficacy and Safety of Henagliflozin in Chinese Adults with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
July 28, 2026 · 0 citations · Open access
Open original record →SGLT2 inhibitors and chronic kidney disease: a narrative review of nephroprotective mechanisms from hemodynamics to metabolism
July 2, 2026 · 2 citations · Open access
Open original record →Real-World Evaluation Of Dapagliflozin And Empagliflozin In Type 2 Diabetes: Cardiorenal And Metabolic Perspectives
June 12, 2026 · 0 citations · Open access
Open original record →Chronic Renocardiac Syndrome (Type 4 Cardiorenal Syndrome): A Comprehensive Review
January 1, 2026 · 0 citations · Open access
Open original record →Dapagliflozin: an effective adjunctive treatment in type 1 diabetes
March 26, 2021 · 1 citations · Open access
Open original record →SGLT2 inhibitor: metabolic effect on Libyan patients with T2DM at National Diabetes Center in Tripoli
June 30, 2020 · 0 citations · Open access
Open original record →